Clinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) trials you may qualify forThe present study is practice-driven and merely observational and prospective. In clinical routine, patients who suffer from suspected ACS and do not show ST el…
Drug-eluting stent (DES)-based primary percutaneous intervention (pPCI) has been established as the standard of care for patients presenting with ST-segment ele…
This is a multi-center, randomized, double-blind, double-dummy, parallel-controled, phase III trial, aiming to evaluate the effectiveness and safety of long-ter…
Patients who are diagnosed with a heart attack are often confronted with an unexpected hospital admission and an urgent heart catheterization. In this stressful…
The Sponsor implemented a post-authorisation safety study (PASS), category 3, focused in Acute Coronary Syndrome, in order to collect information about the safe…
Among patients with acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI) and stent implantation, 17.5% are both at high bleeding…